{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,27]],"date-time":"2026-02-27T04:27:08Z","timestamp":1772166428987,"version":"3.50.1"},"reference-count":57,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,11,30]],"date-time":"2020-11-30T00:00:00Z","timestamp":1606694400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2020,11,30]],"date-time":"2020-11-30T00:00:00Z","timestamp":1606694400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100005001","name":"Ahvaz Jundishapur University of Medical Sciences","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005001","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Trials"],"published-print":{"date-parts":[[2020,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>The prevalence of prediabetes is increasing worldwide. Unfortunately, prediabetes is related to non-communicable diseases. A high risk of developing type 2 diabetes mellitus (T2DM) is reported in people with prediabetes. Curcumin, a polyphenol, might lead to its therapeutic role in obesity and some obesity-related metabolic diseases. Zinc is a trace element that plays a key role in the synthesis and action of insulin, carbohydrate metabolism, and decreasing inflammation. There has been no clinical trial of zinc and curcumin co-supplementation in patients with prediabetes. In previous studies, the single administration of zinc or curcumin has not been conducted on many of the studied markers in prediabetic patients.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>The purpose of this randomized double-blind placebo-controlled clinical trial is to investigate the effect of curcumin and zinc co-supplementation on glycemic measurements, lipid profiles, and inflammatory and antioxidant biomarkers among 84 prediabetic patients with body mass index (BMI) between 25 and 35. Also, liver enzyme, serum zinc, urine zinc, blood pressure, anthropometric parameters, quality of life, adherence to co-supplementation, the side effects of co-supplementation, physical activity, and dietary intake will be assessed. Women or men (18\u201350\u2009years old for men and 18\u2009years to before menopause for women) will be followed for 3\u00a0months (90\u2009days). This study will be conducted at Yazd Diabetes Research Clinic, Shahid Sadoughi University of Medical Sciences.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Discussion<\/jats:title>\n                    <jats:p>A diet rich in antioxidants, polyphenols, and phytochemicals has been shown to have a beneficial role in prediabetes. According to the beneficial properties of curcumin or zinc and inadequate evidence, RCTs are needed to assess the effect of curcumin and zinc co-supplementation in native prediabetes patients. We hope the results of the present trial, negative or positive, fill this gap in the literature and facilitate the approach for a much larger, multi-center clinical trial. In conclusion, a synergic effect of co-supplementation along with a weight-loss diet may delay the progression to type 2 diabetes mellitus.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Trial registration<\/jats:title>\n                    <jats:p>\n                      Iranian Registry of Clinical Trials (IRCT)\n                      <jats:ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"https:\/\/en.irct.ir\/trial\/41874\">IRCT20190902044671N1<\/jats:ext-link>\n                      . Registered on 11 October 2019\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s13063-020-04923-w","type":"journal-article","created":{"date-parts":[[2020,11,30]],"date-time":"2020-11-30T12:05:20Z","timestamp":1606737920000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":14,"title":["Evaluation of the effect of curcumin and zinc co-supplementation on glycemic measurements, lipid profiles, and inflammatory and antioxidant biomarkers in overweight or obese prediabetic patients: a study protocol for a randomized double-blind placebo-controlled phase 2 clinical trial"],"prefix":"10.1186","volume":"21","author":[{"given":"Majid","family":"Karandish","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hassan","family":"Mozaffari-khosravi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Seyed Mohammad","family":"Mohammadi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2110-9817","authenticated-orcid":false,"given":"Maryam","family":"Azhdari","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bahman","family":"Cheraghian","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2020,11,30]]},"reference":[{"key":"4923_CR1","volume-title":"IDF diabetes atlas eighth edition","author":"Federation I","year":"2017","unstructured":"Federation I. IDF diabetes atlas eighth edition. Brussels: International Diabetes Federation; 2017."},{"issue":"Supplement 1","key":"4923_CR2","doi-asserted-by":"publisher","first-page":"S13","DOI":"10.2337\/dc18-S002","volume":"41","author":"American Diabetes Association","year":"2018","unstructured":"American Diabetes Association. 2. Classification and diagnosis of diabetes: standards of medical care in diabetes. Diabetes Care. 2018;41(Supplement 1):S13\u201327.","journal-title":"Diabetes Care"},{"key":"4923_CR3","volume-title":"IDF diabetes atlas","author":"International Diabetes Federation","year":"2017","unstructured":"International Diabetes Federation. Chapter 1 - What is diabetes? In: IDF diabetes atlas. 8th ed; 2017.","edition":"8"},{"key":"4923_CR4","volume-title":"Global report on diabetes","author":"World Health Organization","year":"2016","unstructured":"World Health Organization. Global report on diabetes. 2016."},{"issue":"1","key":"4923_CR5","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1186\/s40842-019-0080-0","volume":"5","author":"U Hostalek","year":"2019","unstructured":"Hostalek U. Global epidemiology of prediabetes-present and future perspectives. Clin Diabetes Endocrinol. 2019;5(1):5.","journal-title":"Clin Diabetes Endocrinol"},{"key":"4923_CR6","doi-asserted-by":"publisher","first-page":"27","DOI":"10.4103\/2277-9175.150415","volume":"4","author":"B Iraj","year":"2015","unstructured":"Iraj B, Salami R, Feizi A, Amini M. The profile of hypertension and dyslipidemia in prediabetic subjects; results of the Isfahan Diabetes Prevention Program: a large population-based study. Adv Biomed Res. 2015;4:27.","journal-title":"Adv Biomed Res"},{"issue":"9833","key":"4923_CR7","doi-asserted-by":"publisher","first-page":"2279","DOI":"10.1016\/S0140-6736(12)60283-9","volume":"379","author":"AG Tab\u00e1k","year":"2012","unstructured":"Tab\u00e1k AG, Herder C, Rathmann W, Brunner EJ, Kivim\u00e4ki M. Prediabetes: a high-risk state for developing diabetes. Lancet. 2012;379(9833):2279.","journal-title":"Lancet"},{"key":"4923_CR8","volume-title":"Prediabetes","author":"S Alvarez","year":"2017","unstructured":"Alvarez S, Algotar AM. Prediabetes; 2017."},{"issue":"3","key":"4923_CR9","doi-asserted-by":"publisher","first-page":"88","DOI":"10.7812\/TPP\/14-002","volume":"18","author":"P Tuso","year":"2014","unstructured":"Tuso P. Prediabetes and lifestyle modification: time to prevent a preventable disease. Perm J. 2014;18(3):88.","journal-title":"Perm J"},{"issue":"1","key":"4923_CR10","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1016\/j.amepre.2004.08.006","volume":"28","author":"SL Norris","year":"2005","unstructured":"Norris SL, Zhang X, Avenell A, Gregg E, Bowman B, Schmid CH, et al. Long-term effectiveness of weight-loss interventions in adults with pre-diabetes: a review. Am J Prev Med. 2005;28(1):126\u201339.","journal-title":"Am J Prev Med"},{"issue":"9","key":"4923_CR11","doi-asserted-by":"publisher","first-page":"853","DOI":"10.1007\/s10654-019-00548-9","volume":"34","author":"N van der Schaft","year":"2019","unstructured":"van der Schaft N, Schoufour JD, Nano J, Kiefte-de Jong JC, Muka T, Sijbrands EJG, et al. Dietary antioxidant capacity and risk of type 2 diabetes mellitus, prediabetes and insulin resistance: the Rotterdam Study. Eur J Epidemiol. 2019;34(9):853\u201361.","journal-title":"Eur J Epidemiol"},{"key":"4923_CR12","doi-asserted-by":"publisher","first-page":"6723931","DOI":"10.1155\/2017\/6723931","volume":"2017","author":"M Guasch-Ferre","year":"2017","unstructured":"Guasch-Ferre M, Merino J, Sun Q, Fito M, Salas-Salvado J. Dietary polyphenols, Mediterranean diet, prediabetes, and type 2 diabetes: a narrative review of the evidence. Oxidative Med Cell Longev. 2017;2017:6723931.","journal-title":"Oxidative Med Cell Longev"},{"key":"4923_CR13","doi-asserted-by":"publisher","first-page":"64","DOI":"10.4103\/ijpvm.IJPVM_145_18","volume":"9","author":"M Abshirini","year":"2018","unstructured":"Abshirini M, Mahaki B, Bagheri F, Siassi F, Koohdani F, Sotoudeh G. Higher intake of phytochemical-rich foods is inversely related to prediabetes: a case-control study. Int J Prev Med. 2018;9:64.","journal-title":"Int J Prev Med"},{"key":"4923_CR14","doi-asserted-by":"crossref","unstructured":"Benzie IF, Wachtel-Galor S. Herbal medicine: biomolecular and clinical aspects. 2nd ed. CRC Press\/Taylor & Francis; 2011.","DOI":"10.1201\/b10787"},{"issue":"2","key":"4923_CR15","first-page":"141","volume":"14","author":"JS Jurenka","year":"2009","unstructured":"Jurenka JS. Anti-inflammatory properties of curcumin, a major constituent of Curcuma longa: a review of preclinical and clinical research. Altern Med Rev. 2009;14(2):141\u201353.","journal-title":"Altern Med Rev"},{"issue":"6","key":"4923_CR16","doi-asserted-by":"publisher","first-page":"524","DOI":"10.1080\/10408391003698677","volume":"51","author":"F Visioli","year":"2011","unstructured":"Visioli F, De La Lastra CA, Andres-Lacueva C, Aviram M, Calhau C, Cassano A, et al. Polyphenols and human health: a prospectus. Crit Rev Food Sci Nutr. 2011;51(6):524\u201346.","journal-title":"Crit Rev Food Sci Nutr"},{"key":"4923_CR17","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1186\/1472-6882-6-10","volume":"6","author":"CD Lao","year":"2006","unstructured":"Lao CD, Ruffin MT, Normolle D, Heath DD, Murray SI, Bailey JM, et al. Dose escalation of a curcuminoid formulation. BMC Complement Altern Med. 2006;6:10.","journal-title":"BMC Complement Altern Med"},{"issue":"2","key":"4923_CR18","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1016\/j.jnutbio.2013.09.013","volume":"25","author":"S Chuengsamarn","year":"2014","unstructured":"Chuengsamarn S, Rattanamongkolgul S, Phonrat B, Tungtrongchitr R, Jirawatnotai S. Reduction of atherogenic risk in patients with type 2 diabetes by curcuminoid extract: a randomized controlled trial. J Nutr Biochem. 2014;25(2):144\u201350.","journal-title":"J Nutr Biochem"},{"issue":"10","key":"4923_CR19","doi-asserted-by":"publisher","first-page":"92","DOI":"10.3390\/foods6100092","volume":"6","author":"SJ Hewlings","year":"2017","unstructured":"Hewlings SJ, Kalman DS. Curcumin: a review of its effects on human health. Foods. 2017;6(10):92.","journal-title":"Foods"},{"issue":"5","key":"4923_CR20","doi-asserted-by":"publisher","first-page":"1289","DOI":"10.1002\/ptr.6323","volume":"33","author":"M Azhdari","year":"2019","unstructured":"Azhdari M, Karandish M, Mansoori A. Metabolic benefits of curcumin supplementation in patients with metabolic syndrome: a systematic review and meta-analysis of randomized controlled trials. Phytother Res. 2019;33(5):1289\u2013301.","journal-title":"Phytother Res"},{"issue":"1","key":"4923_CR21","doi-asserted-by":"publisher","first-page":"854","DOI":"10.1016\/j.dsx.2018.11.051","volume":"13","author":"A Ahangarpour","year":"2019","unstructured":"Ahangarpour A, Sayahi M, Sayahi M. The antidiabetic and antioxidant properties of some phenolic phytochemicals: a review study. Diabetes Metab Syndr Clin Res Rev. 2019;13(1):854\u20137.","journal-title":"Diabetes Metab Syndr Clin Res Rev"},{"issue":"1","key":"4923_CR22","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1097\/NT.0000000000000392","volume":"55","author":"K Singletary","year":"2020","unstructured":"Singletary K. Turmeric: potential health benefits. Nutr Today. 2020;55(1):45\u201356.","journal-title":"Nutr Today"},{"issue":"8","key":"4923_CR23","doi-asserted-by":"publisher","first-page":"2209","DOI":"10.1111\/j.1476-5381.2012.01959.x","volume":"166","author":"B Stefanska","year":"2012","unstructured":"Stefanska B. Curcumin ameliorates hepatic fibrosis in type 2 diabetes mellitus\u2013insights into its mechanisms of action. Br J Pharmacol. 2012;166(8):2209\u201311.","journal-title":"Br J Pharmacol"},{"issue":"3","key":"4923_CR24","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1007\/s00394-011-0188-1","volume":"50","author":"A Shehzad","year":"2011","unstructured":"Shehzad A, Ha T, Subhan F, Lee YS. New mechanisms and the anti-inflammatory role of curcumin in obesity and obesity-related metabolic diseases. Eur J Nutr. 2011;50(3):151\u201361.","journal-title":"Eur J Nutr"},{"issue":"3","key":"4923_CR25","doi-asserted-by":"publisher","first-page":"2985","DOI":"10.3390\/ijms13032985","volume":"13","author":"KH Lee","year":"2012","unstructured":"Lee KH, Chow YL, Sharmili V, Abas F, Alitheen NB, Shaari K, et al. BDMC33, a curcumin derivative suppresses inflammatory responses in macrophage-like cellular system: role of inhibition in NF-\u03baB and MAPK signaling pathways. Int J Mol Sci. 2012;13(3):2985\u20133008.","journal-title":"Int J Mol Sci"},{"issue":"11","key":"4923_CR26","doi-asserted-by":"publisher","first-page":"2121","DOI":"10.2337\/dc12-0116","volume":"35","author":"S Chuengsamarn","year":"2012","unstructured":"Chuengsamarn S, Rattanamongkolgul S, Luechapudiporn R, Phisalaphong C, Jirawatnotai S. Curcumin extract for prevention of type 2 diabetes. Diabetes Care. 2012;35(11):2121\u20137.","journal-title":"Diabetes Care"},{"issue":"1","key":"4923_CR27","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1186\/s12944-019-0967-x","volume":"18","author":"RN Thota","year":"2019","unstructured":"Thota RN, Acharya SH, Garg ML. Curcumin and\/or omega-3 polyunsaturated fatty acids supplementation reduces insulin resistance and blood lipids in individuals with high risk of type 2 diabetes: a randomised controlled trial. Lipids Health Dis. 2019;18(1):31.","journal-title":"Lipids Health Dis"},{"issue":"3","key":"4923_CR28","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1007\/s40292-017-0206-3","volume":"24","author":"AFG Cicero","year":"2017","unstructured":"Cicero AFG, Fogacci F, Morbini M, Colletti A, Bove M, Veronesi M, et al. Nutraceutical effects on glucose and lipid metabolism in patients with impaired fasting glucose: a pilot, double-blind, placebo-controlled, randomized clinical trial on a combined product. High Blood Press Cardiovasc Prev. 2017;24(3):283\u20138.","journal-title":"High Blood Press Cardiovasc Prev"},{"issue":"12","key":"4923_CR29","doi-asserted-by":"publisher","first-page":"1770","DOI":"10.1002\/ptr.5197","volume":"28","author":"YS Yang","year":"2014","unstructured":"Yang YS, Su YF, Yang HW, Lee YH, Chou JI, Ueng KC. Lipid-lowering effects of curcumin in patients with metabolic syndrome: a randomized, double-blind, placebo-controlled trial. Phytother Res. 2014;28(12):1770\u20137.","journal-title":"Phytother Res"},{"issue":"2","key":"4923_CR30","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1016\/j.ctim.2015.01.008","volume":"23","author":"F Amin","year":"2015","unstructured":"Amin F, Islam N, Anila N, Gilani A. Clinical efficacy of the co-administration of turmeric and black seeds (Kalongi) in metabolic syndrome\u2013a double blind randomized controlled trial\u2013TAK-MetS trial. Complement Ther Med. 2015;23(2):165\u201374.","journal-title":"Complement Ther Med"},{"issue":"9","key":"4923_CR31","doi-asserted-by":"publisher","first-page":"1540","DOI":"10.1002\/ptr.5659","volume":"30","author":"S Rahmani","year":"2016","unstructured":"Rahmani S, Asgary S, Askari G, Keshvari M, Hatamipour M, Feizi A, et al. Treatment of non-alcoholic fatty liver disease with curcumin: a randomized placebo-controlled trial. Phytother Res. 2016;30(9):1540\u20138.","journal-title":"Phytother Res"},{"issue":"1","key":"4923_CR32","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1186\/1472-6882-13-104","volume":"13","author":"SJ Grant","year":"2013","unstructured":"Grant SJ, Chang DH-T, Liu J, Wong V, Kiat H, Bensoussan A. Chinese herbal medicine for impaired glucose tolerance: a randomized placebo controlled trial. BMC Complement Altern Med. 2013;13(1):104.","journal-title":"BMC Complement Altern Med"},{"issue":"4","key":"4923_CR33","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1007\/s00204-011-0775-1","volume":"86","author":"CT Chasapis","year":"2012","unstructured":"Chasapis CT, Loutsidou AC, Spiliopoulou CA, Stefanidou ME. Zinc and human health: an update. Arch Toxicol. 2012;86(4):521\u201334.","journal-title":"Arch Toxicol"},{"issue":"2","key":"4923_CR34","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1080\/07315724.1998.10718735","volume":"17","author":"AB Chausmer","year":"1998","unstructured":"Chausmer AB. Zinc, insulin and diabetes. J Am Coll Nutr. 1998;17(2):109\u201315.","journal-title":"J Am Coll Nutr"},{"issue":"1","key":"4923_CR35","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1007\/s10787-017-0309-4","volume":"25","author":"M Jarosz","year":"2017","unstructured":"Jarosz M, Olbert M, Wyszogrodzka G, Mlyniec K, Librowski T. Antioxidant and anti-inflammatory effects of zinc. Zinc-dependent NF-\u03baB signaling. Inflammopharmacology. 2017;25(1):11\u201324.","journal-title":"Inflammopharmacology"},{"issue":"1","key":"4923_CR36","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1186\/1758-5996-4-13","volume":"4","author":"R Jayawardena","year":"2012","unstructured":"Jayawardena R, Ranasinghe P, Galappatthy P, Malkanthi R, Constantine G, Katulanda P. Effects of zinc supplementation on diabetes mellitus: a systematic review and meta-analysis. Diabetol Metab Syndr. 2012;4(1):13.","journal-title":"Diabetol Metab Syndr"},{"issue":"1","key":"4923_CR37","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1186\/s12986-015-0023-4","volume":"12","author":"P Ranasinghe","year":"2015","unstructured":"Ranasinghe P, Wathurapatha W, Ishara M, Jayawardana R, Galappatthy P, Katulanda P, et al. Effects of zinc supplementation on serum lipids: a systematic review and meta-analysis. Nutr Metab. 2015;12(1):26.","journal-title":"Nutr Metab"},{"issue":"4","key":"4923_CR38","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1177\/002215540104900412","volume":"49","author":"B Lukowiak","year":"2001","unstructured":"Lukowiak B, Vandewalle B, Riachy R, Kerr-Conte J, Gmyr V, Belaich S, et al. Identification and purification of functional human \u03b2-cells by a new specific zinc-fluorescent probe. J Histochem Cytochem. 2001;49(4):519\u201328.","journal-title":"J Histochem Cytochem"},{"key":"4923_CR39","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/j.diabres.2016.03.010","volume":"115","author":"MR Islam","year":"2016","unstructured":"Islam MR, Attia J, Ali L, McEvoy M, Selim S, Sibbritt D, et al. Zinc supplementation for improving glucose handling in pre-diabetes: a double blind randomized placebo controlled pilot study. Diabetes Res Clin Pract. 2016;115:39\u201346.","journal-title":"Diabetes Res Clin Pract"},{"issue":"5","key":"4923_CR40","doi-asserted-by":"publisher","first-page":"386","DOI":"10.1111\/1753-0407.12621","volume":"10","author":"P Ranasinghe","year":"2018","unstructured":"Ranasinghe P, Wathurapatha WS, Galappatthy P, Katulanda P, Jayawardena R, Constantine GR. Zinc supplementation in prediabetes: a randomized double-blind placebo-controlled clinical trial. J Diabetes. 2018;10(5):386\u201397.","journal-title":"J Diabetes"},{"key":"4923_CR41","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1016\/j.jtemb.2018.03.022","volume":"48","author":"H-N Kim","year":"2018","unstructured":"Kim H-N, Kim S-H, Eun Y-M, Song S-W. Effects of zinc, magnesium, and chromium supplementation on cardiometabolic risk in adults with metabolic syndrome: a double-blind, placebo-controlled randomised trial. J Trace Elem Med Biol. 2018;48:166\u201371.","journal-title":"J Trace Elem Med Biol"},{"key":"4923_CR42","doi-asserted-by":"publisher","first-page":"7","DOI":"10.4137\/NMI.S23233","volume":"8","author":"A Bogale","year":"2015","unstructured":"Bogale A, Clarke SL, Fiddler J, Hambidge KM, Stoecker BJ. Zinc supplementation in a randomized controlled trial decreased ZIP4 and ZIP8 mRNA abundance in peripheral blood mononuclear cells of adult women. Nutr Metab Insights. 2015;8:7\u201314.","journal-title":"Nutr Metab Insights"},{"issue":"1","key":"4923_CR43","first-page":"88","volume":"14","author":"MH Lotfi","year":"2013","unstructured":"Lotfi MH, Saadati H, Afzali M. Prevalence of diabetes in people aged \u226530 years: the results of screening program of Yazd Province, Iran, in 2012. J Res Health Sci. 2013;14(1):88\u201392.","journal-title":"J Res Health Sci"},{"issue":"4","key":"4923_CR44","doi-asserted-by":"publisher","first-page":"653","DOI":"10.1016\/j.tiv.2009.03.003","volume":"23","author":"S Pavlica","year":"2009","unstructured":"Pavlica S, Gaunitz F, Gebhardt R. Comparative in vitro toxicity of seven zinc-salts towards neuronal PC12 cells. Toxicol in Vitro. 2009;23(4):653\u20139.","journal-title":"Toxicol in Vitro"},{"key":"4923_CR45","unstructured":"Energy requirements of adults. In: FAO food and nutrition technical report series. Human energy requirements: report of a joint FAO\/WHO\/UNU expert consultation. Food Nutr Bull. 2005; 26(1):35\u201350."},{"issue":"6","key":"4923_CR46","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1056\/NEJMoa012512","volume":"346","author":"WC Knowler","year":"2002","unstructured":"Knowler WC, Barrett-Connor E, Fowler SE, Hamman RF, Lachin JM, Walker EA, Diabetes Prevention Program Research Group, et al. Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N Engl J Med. 2002;346(6):393\u2013403.","journal-title":"N Engl J Med"},{"key":"4923_CR47","unstructured":"Acceptable macronutrient distribution ranges. In: Otten J. Hellwig J. Meyer L. Dietary Reference Intakes. Washington, DC: National Academies Press; 2006. p. 70."},{"issue":"7","key":"4923_CR48","doi-asserted-by":"publisher","first-page":"e39504","DOI":"10.1371\/journal.pone.0039504","volume":"7","author":"NY Krakauer","year":"2012","unstructured":"Krakauer NY, Krakauer JC. A new body shape index predicts mortality hazard independently of body mass index. PLoS One. 2012;7(7):e39504.","journal-title":"PLoS One"},{"key":"4923_CR49","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1161\/01.HYP.0000150859.47929.8e","volume":"45","author":"T Pickering","year":"2005","unstructured":"Pickering T, Hall J, Appel L, Falkner B, Graves J, Hill M, et al. Recommendations for blood pressure measurement in humans. A statement for professionals from the subcommittee of Professional and Public Education of the American Heart Association Council on High Blood Pressure Research. Hypertension. 2005;45:142\u201361.","journal-title":"Hypertension"},{"key":"4923_CR50","first-page":"809","volume":"3","author":"N Rifai","year":"1999","unstructured":"Rifai N, Bachorik PS, Albers JJ. Lipids, lipoproteins and apolipoproteins. Tietz Textbook Clin Chem. 1999;3:809\u201361.","journal-title":"Tietz Textbook Clin Chem"},{"issue":"2","key":"4923_CR51","doi-asserted-by":"publisher","first-page":"142","DOI":"10.4162\/nrp.2010.4.2.142","volume":"4","author":"YJ Yang","year":"2010","unstructured":"Yang YJ, Kim MK, Hwang SH, Ahn Y, Shim JE, Kim DH. Relative validities of 3-day food records and the food frequency questionnaire. Nutr Res Pract. 2010;4(2):142\u20138.","journal-title":"Nutr Res Pract"},{"issue":"2","key":"4923_CR52","doi-asserted-by":"publisher","first-page":"106","DOI":"10.5812\/asjsm.34781","volume":"2","author":"A Vasheghani-Farahani","year":"2011","unstructured":"Vasheghani-Farahani A, Tahmasbi M, Asheri H, Ashraf H, Nedjat S, Kordi R. The Persian, last 7-day, long form of the International Physical Activity Questionnaire: translation and validation study. Asian J Sports Med. 2011;2(2):106.","journal-title":"Asian J Sports Med"},{"issue":"8","key":"4923_CR53","doi-asserted-by":"publisher","first-page":"1381","DOI":"10.1249\/01.MSS.0000078924.61453.FB","volume":"35","author":"CL Craig","year":"2003","unstructured":"Craig CL, Marshall AL, Sj\u00f6str\u00f6m M, Bauman AE, Booth ML, Ainsworth BE, et al. International Physical Activity Questionnaire: 12-country reliability and validity. Med Sci Sports Exerc. 2003;35(8):1381\u201395.","journal-title":"Med Sci Sports Exerc"},{"issue":"3","key":"4923_CR54","doi-asserted-by":"publisher","first-page":"875","DOI":"10.1007\/s11136-004-1014-5","volume":"14","author":"A Montazeri","year":"2005","unstructured":"Montazeri A, Goshtasebi A, Vahdaninia M, Gandek B. The Short Form Health Survey (SF-36): translation and validation study of the Iranian version. Qual Life Res. 2005;14(3):875\u201382.","journal-title":"Qual Life Res"},{"issue":"11","key":"4923_CR55","doi-asserted-by":"publisher","first-page":"1565","DOI":"10.1016\/S0959-8049(99)00192-6","volume":"35","author":"D Osoba","year":"1999","unstructured":"Osoba D. What has been learned from measuring health-related quality of life in clinical oncology. Eur J Cancer. 1999;35(11):1565\u201370.","journal-title":"Eur J Cancer"},{"issue":"6","key":"4923_CR56","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1097\/00005650-199206000-00002","volume":"30","author":"IC Framework","year":"1992","unstructured":"Framework IC. The MOS 36-item short-form health survey (SF-36). Med Care. 1992;30(6):473\u201383.","journal-title":"Med Care"},{"issue":"12","key":"4923_CR57","doi-asserted-by":"publisher","first-page":"1207","DOI":"10.4239\/wjd.v6.i12.1207","volume":"6","author":"M Kanat","year":"2015","unstructured":"Kanat M, DeFronzo RA, Abdul-Ghani MA. Treatment of prediabetes. World J Diabetes. 2015;6(12):1207.","journal-title":"World J Diabetes"}],"container-title":["Trials"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13063-020-04923-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s13063-020-04923-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13063-020-04923-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,11,30]],"date-time":"2020-11-30T12:39:37Z","timestamp":1606739977000},"score":1,"resource":{"primary":{"URL":"https:\/\/trialsjournal.biomedcentral.com\/articles\/10.1186\/s13063-020-04923-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,11,30]]},"references-count":57,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["4923"],"URL":"https:\/\/doi.org\/10.1186\/s13063-020-04923-w","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-42301\/v1","asserted-by":"object"}]},"ISSN":["1745-6215"],"issn-type":[{"value":"1745-6215","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,11,30]]},"assertion":[{"value":"1 September 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 November 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 November 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This trial was approved by the Medical Ethics Committee of Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran (ethical code: IR.AJUMS.REC.1398.504) in accordance with the ethical standards of the institutional and\/or national research committee and with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards. A voluntary informed consent will be provided by all participants included in the study before initiating any study procedure. All collected data will be held confidential.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no conflict of interest.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"991"}}